Symyoo was designated as a global coordinating center to run late phase multinational clinical trials for Covid-19 medication development. The trials are conducted widely across Korea and European countrie. Symyoo understands well that the trial operations should be very specific to the risk and complexity of each region/country where the trials are conducted.